Over the past decades the global population is focusing towards minimally invasive procedures to treat variety of medical and aesthetic imperfections such as scars, wrinkles, skin discolorations, unwanted spots, excess fat, spider veins etc. Increasing benefit for combination therapies in aesthetic medicines is leading to its widespread acceptance among population of all age groups. In the U.S., a large base of population, especially youngsters, suffer from various forms of skin disorders such as acne vulgaris, psoriasis, vitiligo, shingles, chickenpox, etc. These disorders are characterized by left over scars during the recovery, and affect the appearance and confidence of the youngsters. Estimated by the American Academy of Dermatology, approximately 7.5 million people in the U.S. suffer from psoriasis currently. The most common form of psoriasis is plaque psoriasis, affecting about 80-90% of psoriasis patients in the country. The disease is characterized by patches of raised, reddish skin covered with silvery-white scale. Facial ageing is recognized by volume loss in the face which is another important pillar of aesthetic medicine. In such cases facelift procedures proves to be an effective treatment regime wherein facelifts reposition tissue and remove the deeper lines and folds and lasers remove fine lines and discoloration. Combination therapies such as botulinum toxin with dermal fillers, chemical peels and laser resurfacing proves to be effective and affordable treatment regime in case of facial rejuvenation. Nowadays few dermatologists use monotherapy for acne treatment. The global market of combination therapy in aesthetics medicines is expected witness healthy growth attributed to its ease of application and with minimum or no downtime.
The demand for combination treatments in aesthetics is rapidly growing as a result of early onset of aging which is driving demand for age-defying treatments. According to the World Population Report 2015 published by the United Nations, the global population is ageing at 1.18% per annum. Each year, approximately 83 million people are reaching the age group over 60 years per year. In addition changing demand patterns for less painful treatments by consumers is increasing the demand for combination therapies over the forecast period. On the other hand increasing demand for clinically-evidenced ingredients is boosting surgico-medical cosmetic procedures. In this regard, the American Society of Plastic Surgeons (ASPS) noted that 15.6 Mn cosmetic procedures were performed in the U.S. in 2014. Wider array of cosmetic treatment options provided by various drug and device makers is expected to fuel growth for combination therapies in aesthetics market globally.
Combination therapies can sometimes lead to adverse reactions impacting overall appearance of an individual undergoing therapy. Also high cost per procedure deter customers from repeated visits thus impacting the growth of the market in economically unstable countries for combination therapies in the near future.
Minimally invasive and personalized age-defying treatments create demand for face and skin related problems ultimately leading to accelerated market growth in the near future. In addition increasing demand for synergistic effect in combination of reflation and relaxation rejuvenation therapies and dominance of inexpensive non-surgical treatments, especially botulinum products as compared to surgical treatments is expected to create demand for combination therapies in the near future.
On the basis of region presence, combination therapies in aesthetics market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia pacific excluding Japan, Japan, and Middle East and Africa. North America and Europe are the biggest markets for the combination therapies in aesthetics market. North America market is expected to continue to dominate over the next few years due to higher number of U.S. FDA approvals for botulinum products in the region. Meanwhile, it is harder to get Health Canada approval. Asia Pacific market is comparatively smaller and less penetrated than other regional markets, but also represents providers the fastest potential opportunity due to rising patient awareness for various therapeutic options and increasing accessibility to these procedures. Combination treatments such wrinkle lifting plus volume restoring are gaining popularity in this region. Healthy economic growth and disposable income levels in Brunei, Cambodia, Indonesia, Laos, Malaysia, Philippines, Singapore, Thailand, and Vietnam contribute largely to increasing demand for facial injectable products.
Some of the key market players in the combination therapies in aesthetics market are Merz Pharmaceuticals, Lumenis, Biopolymer GmbH &Co KG, Revance Therapeutics, Inc.,Mentor Worldwide LLC, Alma Lasers, Anika Therapeutics, Inc., Contura International A/S, Cynosure, Inc., Fibrocell, Inc., Gal derma S/A and others.
A Sample of this Report is Available Upon Request @http://www.persistencemarketresearch.com/samples/10987
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, product types, and End Users.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/10987